IGFBP7 and neoplasm: Nonetheless, normalization of tumor vasculature has been found to promote a host of favorable alterations to the TME, as we have recently demonstrated in preclinical murine models by disrupting CD93 interaction with IGFBP7/MMRN2 [14].